Universidad Peruana Cayetano Heredia

Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections

Mostrar el registro sencillo del ítem

dc.contributor.author Guerra, Jorge G.
dc.contributor.author Falconi, E.
dc.contributor.author Palomino, J.C.
dc.contributor.author Benavente, Luis
dc.contributor.author Antunez de Mayolo, E.
dc.date.accessioned 2022-10-09T23:25:32Z
dc.date.available 2022-10-09T23:25:32Z
dc.date.issued 1983
dc.identifier.uri https://hdl.handle.net/20.500.12866/12314
dc.description.abstract Forty patients with urinary tract infections were randomly assigned to receive a ten-day course of oral therapy with either norfloxacin 400 mg twice daily or cotrimoxazole (trimethoprim-sulfamethoxazole) 160/800 mg twice daily. There were 34 cases (19 in the norfloxacin and 15 in the cotrimoxazole group) of evaluable infections due to Escherichia coli (85 % of cases), Klebsiella pneumoniae, Enterobacter spp., Proteus vulgaris and Alcaligenes faecalis. All organisms were sensitive to the assigned study drug. Twenty-two strains of Escherichia coli and five other isolates had a norfloxacin MIC50 of 0.03 mg/l and MIC90 of 1.0 mg/l. All patients were cured of the initial infection. Three diabetic patients in the norfloxacin group and another healthy patient in the cotrimoxazole group experienced asymptomatic recurrences due to organisms of the same species which, in the absence of causes of bacterial persistence, were considered to be reinfections. Mild reversible adverse effects of no clinical significance were observed in nine patients in each treatment group. Norfloxacin seems to be as effective and safe as cotrimoxazole in the conventional treatment of uncomplicated urinary tract infection. en_US
dc.language.iso eng
dc.publisher Springer
dc.relation.ispartofseries European Journal of Clinical Microbiology and Infectious Diseases
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Clinical Significance en_US
dc.subject Diabetic Patient en_US
dc.subject Urinary en_US
dc.subject Tract Infection en_US
dc.subject Clinical Evaluation en_US
dc.subject Study Drug en_US
dc.title Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1007/BF02029529
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#1.06.01
dc.relation.issn 1435-4373


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas